Actively Recruiting

Age: 70Years +
All Genders
NCT04414865

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Led by Shanghai MicroPort CardioFlow Medtech Co., Ltd. · Updated on 2020-06-04

100

Participants Needed

2

Research Sites

400 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study objective is to evaluate safety and effectiveness/performance of the Microport™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System for the treatment of severe aortic stenosis in the real world settings.

CONDITIONS

Official Title

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Who Can Participate

Age: 70Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 6570 years
  • Symptomatic, calcified, severe, degenerative native aortic valve stenosis with peak velocity 654.0m/s, or mean transvalvular gradient 6540mmHg, or aortic valve area <0.8cm�b2 (or EOA index <0.5cm�b2/m�b2)
  • Not suitable for surgical aortic valve replacement (SAVR)
  • Willing to sign informed consent and agree to scheduled follow-up
Not Eligible

You will not qualify if you...

  • Aortic root anatomy not suitable for transcatheter aortic valve implantation
  • Vascular diseases or anatomical conditions preventing device access
  • Previous implantation of mechanical or bioprosthesis valve in the aortic position
  • Known hypersensitivity or contraindication to anticoagulation/antiplatelet regimens, nitinol, contrast media, or related elements
  • Ongoing sepsis or active endocarditis
  • Estimated life expectancy less than 12 months
  • Participating in another trial without achieving primary endpoint
  • Unable to comply with follow-up or other study requirements

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Ruijing Hospital,Jiaotong University School of Medicine

Shanghai, Shanghai Municipality, China

Not Yet Recruiting

2

Zhongshan Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

Loading map...

Research Team

Z

Zhujun Cai, PhD

CONTACT

J

Jie Bi

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here